Luxembourg - Re-Export of Vaccines for Human Use
Since 2014, Luxembourg Re-Export of Vaccines for Human Use jumped by 15.8% year on year. At $4,706.78 in 2019, the country was number 19 among other countries in Re-Export of Vaccines for Human Use. Luxembourg is overtaken by Trinidad and Tobago, which was ranked number 18 at $5,484 and is followed by Guyana at $4,133.96. United States topped the ranking with $21,386,560.62 in 2019, that is a decrease of 18% compared to 2018. United Arab Emirates, Canada and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Guyana witnessed the best average annual growth at +106.5% per year, while Trinidad and Tobago witnessed the worst performance at -49.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 4,706.78 |
| 2018 | 5,015.83 |
| 2017 | 1,275.01 |
| 2016 | 11,196.00 |
| 2015 | 12,839.00 |
Download all data from 2008 to 2019
How does Luxembourg rank in Re-Export of Vaccines for Human Use?
| # | 22 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
21,386,560.62 | 2019 | -18.0 % | -6.8 % | View data | |
| 2 |
#2
United Arab Emirates
|
7,990,507.15 | 2019 | +36.5 % | +27.7 % | View data | |
| 18 |
#18
Trinidad and Tobago
|
5,484.00 | 2015 | NA | -49.8 % | View data | |
| 19 |
#19
Luxembourg
|
4,706.78 | 2019 | -6.2 % | +15.8 % | View data | |
| 20 |
#20
Guyana
|
4,133.96 | 2017 | NA | +106.5 % | View data | |